SCHEMBL7801944

SCHEMBL7801944

CCOC(=O)C(CC(=O)c1cccc(OC)c1)(NC(C)=O)C(=O)OCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
RECQL P46063 1/20 0.50
PKM P14618 2/20 0.46
KDM4E B2RXH2 1/20 0.46
MTNR1A P48039 3/20 0.45
MTNR1B P49286 3/20 0.45
HSD11B1 P28845 1/20 0.45
THRB P10828 1/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
POLB P06746 1/20 0.44
BLM P54132 1/20 0.44
MAPT P10636 2/20 0.44
HTT P42858 1/20 0.44
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7800751 0.85 ALDH1A1 (0.60) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL7799507 0.85 CHRM2 (0.47) ALDH1A1KDM4EMTNR1AMTNR1BHSD11B1
SCHEMBL7799486 0.84 POLB (0.54) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL7800778 0.84 ALDH1A1 (0.51) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL5036126 0.83 ALDH1A1 (0.66) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL7791489 0.82 ALDH1A1 (0.49) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL4722606 0.81 ALDH1A1 (0.51) ALDH1A1KDM4EHSD11B1NPC1RAB9A
SCHEMBL2468547 0.81 ALDH1A1 (0.47) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL16143340 0.80 ALDH1A1 (0.57) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL14101816 0.78 ALDH1A1 (0.48) ALDH1A1KDM4EHSD11B1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010008947-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES VARASI MARIO (IT) 2001-07-19 US disclosed
EP-0662948-B1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES WITH KYNURENINASE AND/OR KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA & UPJOHN SPA (IT) 1998-10-07 EP disclosed
EP-0662948-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES WITH KYNURENINASE AND/OR KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA & UPJOHN S.p.A. (IT) 1995-07-19 EP disclosed
WO-1995003271-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES WITH KYNURENINASE AND/OR KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA S.P.A. (IT) 1995-02-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010008947-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES KYNU, KMO, ABAT ALDH1A1 615/4885RECQL 4560/4885PKM 381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.